Aster DM Healthcare has clarified ongoing negotiations regarding a strategic acquisition of Quality Care India Limited (QCIL) amid reports of a deal. The company plans to acquire approximately 1,90,46,028 equity shares of QCIL through a preferential allotment, issuing 1,86,07,969 new shares at ₹456.33 each, reflecting a transaction value of around ₹849 crore. This merger aims to bolster operational scale and financial resilience, integrating QCIL's multi-specialty services into Aster's portfolio. Investor sentiment may lean positively as this move enhances growth prospects, although there are related complexities in shareholder structures post-merger.